PREGNYL (choriogonadotropin alfa) by Merck & Co. is clinical pharmacology the action of human chorionic gonadotropin (hcg) is virtually identical to that of pituitary lh, although hcg appears to have a small degree of fsh activity as well. First approved in 1976.
Drug data last refreshed 18h ago · AI intelligence enriched 2w ago
PREGNYL is human chorionic gonadotropin (hCG) alfa, a gonadotropin used to support reproductive function in both males and females. It mimics luteinizing hormone (LH) by stimulating gonadal steroid production, triggering ovulation in females and supporting androgen production in males. The drug has been a foundational therapy in fertility treatment for nearly 50 years.
Low-revenue mature product with minimal recent growth; legacy brand team likely operating at efficiency mode with small staff.
CLINICAL PHARMACOLOGY The action of human chorionic gonadotropin (hCG) is virtually identical to that of pituitary LH, although hCG appears to have a small degree of FSH activity as well. It stimulates production of gonadal steroid hormones by stimulating the interstitial cells (Leydig cells) of…
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
PREGNYL is not currently generating active job postings on pharma career platforms, reflecting its mature, low-growth status. Career opportunities on this product are likely limited to small maintenance teams focused on compliance and legacy account management.
Worked on PREGNYL at Merck & Co.? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access Medicare Part D spending data and other premium pharma intelligence.
Upgrade to Pro — $25/mo